FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Turbare Manufacturing Avastin 1 Recall

Avastin 1

Turbare Manufacturing · Conway, AR

Risk level
Class II
Reported by FDA
Mar 5, 2025
Recall ID
D-0248-2025
Check your lot numberHow we source this data

Summary

Turbare Manufacturing recalled Avastin 1 starting Feb 18, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0248-2025 on Mar 5, 2025. Reason: Lack of Assurance of Sterility: due to a quality control process deviation. Status: Completed.

Why it was recalled

Lack of Assurance of Sterility: due to a quality control process deviation

Product description

Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.

Lot numbers, UPCs & expiration codes

Lot #s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025).

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0248-2025
Classification
Class II
Status
Completed
Recall initiated
Feb 18, 2025
FDA report date
Mar 5, 2025
Quantity
1,147 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Turbare Manufacturing

Original FDA data

Every field from FDA enforcement report D-0248-2025, exactly as published.

Show all FDA fields
City
Conway
State
AR
Status
Completed
Country
United States
Event ID
96306
Address
925 Jeanette Dr
Code information
Lot #s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025).
Postal code
72032-6651
Report date
Mar 5, 2025
Product type
Drugs
Recall number
D-0248-2025
Classification
Class II
Recalling firm
Turbare Manufacturing
Product quantity
1,147 syringes
Termination date
Feb 26, 2026
Reason for recall
Lack of Assurance of Sterility: due to a quality control process deviation
Voluntary / mandated
Voluntary: Firm initiated
Product description
Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.
Distribution pattern
Nationwide in the USA
Recall initiation date
Feb 18, 2025
Initial firm notification
E-Mail
Center classification date
Feb 21, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0248-2025, published Mar 5, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls